X4 Pharmaceuticals, Inc. Common Stock

AED14.8
AED
Last updated on --.
24h volume213.39K
24h highest15.2878 AED
24h lowest14.6185 AED
24h Price movement+0.75%

XFOR recent prices

24 Hours
+0.75%+AED0.11019
30 days
-2.06%-AED0.31221
60 days
+1.13%+AED0.16529
90 days
+17.30%+AED2.185

Key data

Previous close14.6920 AED
Market cap1.31B AED
Volume213.39K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-3.8934 AED
Net income (FY)-366.28M AED
Revenue (FY)33.11M AED
Last report dateMay 6, 2026

About X4 Pharmaceuticals, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersBOSTON
Employees (FY)45.00
Revenue per employee (FY)735.74K AED
Net income per employee (FY)-8.14M AED
Listed onNasdaq
Official website

XFOR conversion tables

XFORXFOR
AEDAED
0.5 XFOR7.401 AED
1 XFOR14.8 AED
5 XFOR74.01 AED
10 XFOR148.02 AED
AEDAED
XFORXFOR
0.5 AED0.033779 XFOR
1 AED0.067558 XFOR
5 AED0.33779 XFOR
10 AED0.67558 XFOR

FAQ

XFOR is trading at AED14.80, +0.75% over the last 24 hours. Track live moves on the price chart at the top of this page.
The XFOR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. XFOR is currently trading at AED14.80, +0.75% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on XFOR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. XFOR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from XFOR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against XFOR's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
X4 Pharmaceuticals, Inc. Common Stock's market cap is currently 1.31B AED. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume213.39K
24h highest15.2878 AED
24h lowest14.6185 AED
24h Price movement+0.75%
XFORXFOR
AEDAED
Start trade with XFOR Perpetual